Aberrant Splicing and Premature Termination of Transcription of the FVIII Gene as a Cause of Severe Canine Hemophilia A: Similarities With the Intron 22 Inversion Mutation in Human Hemophilia

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0037-1613063
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Pharmacokinetics and Pharmacodynamics of SCT800, a New Recombinant FVIII, in Hemophilia a Mice

Acta Pharmacologica Sinica
MedicinePharmacology
2016English

Acquired Hemophilia a as a Cause of Acute Upper Gastrointestinal Hemorrhage

BMJ Case Reports
Medicine
2014English

A Novel Missense Mutation of F 9 Gene in Hemophilia B Patients

Journal of Blood Disorders & Transfusion
2017English

Psy112 - Factor Utilization Analysis of Extended Duration and Standard-Acting Recombinant Fviii Treatments for Severe Hemophilia a in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

MPP1/p55 Gene Deletion in a Hemophilia a Patient With Ectrodactyly and Severe Developmental Defects

American Journal of Hematology
Hematology
2018English

Activation State of Platelets in Experimental Severe Hemophilia A

Haematologica
Hematology
2012English

Severe Hemophilia B

2020English

Cancers in Patients With Hemophilia: A Retrospective Study From the Italian Association of Hemophilia Centers

Journal of Thrombosis and Haemostasis
MedicineHematology
2012English

Efficacy of Standard Prophylaxis Versus On-Demand Treatment With Bayer's Sucrose-Formulated Recombinant FVIII (rFVIII-FS) in Chinese Children With Severe Hemophilia A

Pediatric Hematology and Oncology
Child HealthOncologyPediatricsPerinatologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy